← All diseases
Brain and nervous system
Lewy body dementia
Do you want to receive a message when there is new research about Lewy body dementia? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence appears above each publication explaining what was studied — and you receive a message as soon as there is new research about Lewy body dementia. View what Premium costs.
Publications and studies (1347)
- Commentary or editorialiAn expert's opinion or commentary, not new research. Neurodegeneration in Lewy body dementia linked to T helper cells. (2021/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Neuropathological evidence of body-first vs. brain-first Lewy body disease. (2021/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Clinicopathological heterogeneity of Alzheimer's disease with pure Alzheimer's disease pathology: Cases associated with dementia with Lewy bodies, very early-onset dementia, and primary progressive aphasia. (2021/12/01) ♡
- Twilight and Me: A Soliloquy. (2021/12/01) ♡
- Leveraging virtual reality to train certified nursing assistants as essential dementia-care personnel in the age of COVID-19. (2021/12/01) ♡
- Small Fiber Neuropathy Incidence, Prevalence, Longitudinal Impairments, and Disability. (2021/11/30) ♡
- Impact of neurodegenerative diseases on human adult hippocampal neurogenesis. (2021/11/26) ♡
- Glitazone Treatment Rescues Phenotypic Deficits in a Fly Model of Gaucher/Parkinson's Disease. (2021/11/25) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances in dementia with Lewy bodies. (2021/11/23) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. It Is Time to Study Overlapping Molecular and Circuit Pathophysiologies in Alzheimer's and Lewy Body Disease Spectra. (2021/11/18) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Orexin-A in Patients With Lewy Body Disease: A Systematic Review and Meta-Analysis. (2021/11/17) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Alpha-Synuclein and Cognitive Decline in Parkinson Disease. (2021/11/16) ♡
- Prediction of P-tau/Aβ42 in the cerebrospinal fluid with blood microRNAs in Alzheimer's disease. (2021/11/15) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Cortical circuit dysfunction in a mouse model of alpha-synucleinopathy in vivo. (2021/11/15) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Autoimmunity in neurodegeneration. (2021/11/12) ♡
- Tyrosine 136 phosphorylation of α-synuclein aggregates in the Lewy body dementia brain: involvement of serine 129 phosphorylation by casein kinase 2. (2021/11/12) ♡
- The Feasibility of Differentiating Lewy Body Dementia and Alzheimer's Disease by Deep Learning Using ECD SPECT Images. (2021/11/12) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Autophagy in α-Synucleinopathies-An Overstrained System. (2021/11/12) ♡
- Disease Duration Influences Gene Expression in Neuromelanin-Positive Cells From Parkinson's Disease Patients. (2021/11/11) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Concomitant Alzheimer's and Lewy-Related Pathology Extending the Spectrum of Underlying Pathologies of Corticobasal Syndrome. (2021/11/03) ♡
- Automatic 3D Video Analysis of Upper and Lower Body Movements to Identify Isolated REM Sleep Behavior Disorder: A Pilot Study(). (2021/11/01) ♡
- Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson's disease and dementia with Lewy bodies. (2021/10/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. VGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseases. (2021/10/27) ♡
- Interaction between coxsackievirus B3 infection and α-synuclein in models of Parkinson's disease. (2021/10/25) ♡
- Dementia subtype prediction models constructed by penalized regression methods for multiclass classification using serum microRNA expression data. (2021/10/22) ♡
- A Quantitative Perspective of Alpha-Synuclein Dynamics - Why Numbers Matter. (2021/10/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Examining the Toxicity of α-Synuclein in Neurodegenerative Disorders. (2021/10/22) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Amyloid-Beta Peptides and Activated Astroglia Impairs Proliferation of Nerve Growth Factor Releasing Cells In Vitro: Implication for Encapsulated Cell Biodelivery-Mediated AD Therapy. (2021/10/21) ♡
- Chinese expert consensus statement for diagnosis and treatment of dementia with Lewy bodies 2020. (2021/10/20) ♡
- On the Cluster Formation of α-Synuclein Fibrils. (2021/10/19) ♡
- The Department of Veterans Affairs Gulf War Veterans' Illnesses Biorepository: Supporting Research on Gulf War Veterans' Illnesses. (2021/10/14) ♡
- Relationship between objectively measured physical activity on neuropathology and cognitive outcomes in older adults: Resistance versus resilience? (2021/10/14) ♡
- Uniformity of cardiac (123)I-MIBG uptake on SPECT images in older adults with normal cognition and patients with dementia. (2021/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Structural and Functional Insights into α-Synuclein Fibril Polymorphism. (2021/09/28) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Elderly-Onset Multiple System Atrophy with Lewy Body Pathology: A Case Report. (2021/09/14) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Treatment Efficacy and Acceptabilityof Pharmacotherapies for Dementia with Lewy Bodies: A Systematic Review and Network Meta-Analysis. (2021/09/01) ♡
- The prevalence and co-incidence of geriatric syndromes in older patients with early-stage Alzheimer's disease and dementia with Lewy bodies. (2021/09/01) ♡
- Usefulness of texture analysis in (123)I-FP-CIT for the differentiation of AD and DLB subtypes. (2021/09/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Lack of evidence to support the conclusion that dopaminergic imaging is useful to diagnose mild cognitive impairment with Lewy bodies. (2021/09/01) ♡
- Medications causing potential cognitive impairment are common in nursing home dementia units - A cross-sectional study. (2021/08/05) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Alteration in cerebrospinal fluid (CSF) markers associated with α-synucleinopathies. (2021/08/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Mortality rates in Alzheimer's disease and non-Alzheimer's dementias: a systematic review and meta-analysis. (2021/08/01) ♡
- Criminal Behavior in the Four Years Preceding Diagnosis of Neurocognitive Disorder: A Nationwide Register Study in Finland. (2021/07/01) ♡
- Update on Major Neurocognitive Disorders. (2021/07/01) ♡
- Next-Generation RNA-Sequencing of Serum Small Extracellular Vesicles Discovers Potential Diagnostic Biomarkers for Dementia With Lewy Bodies. (2021/06/01) ♡
- The revised Addenbrooke's Cognitive Examination can facilitate differentiation of dementia with Lewy bodies from Alzheimer's disease. (2021/06/01) ♡
- Association of cerebral microbleeds with cerebrospinal fluid Alzheimer-biomarkers and clinical symptoms in early dementia with Lewy bodies. (2021/06/01) ♡
- [(11)C]MODAG-001-towards a PET tracer targeting α-synuclein aggregates. (2021/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cognitive Impairment in Parkinson's Disease: Epidemiology, Clinical Profile, Protective and Risk Factors. (2021/05/13) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Added Value of QEEG for the Differential Diagnosis of Common Forms of Dementia. (2021/05/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.